Teplizumab Beneficial for Preserving Beta-Cell Function in Pediatric T1D

MONDAY, Oct. 23, 2023 -- For children and adolescents with newly diagnosed type 1 diabetes, two 12-day courses of teplizumab show benefit for preservation of beta (β)-cell function, according to a study published online Oct. 18 in the New...